Nephrectomy: Clinical Trials

34 trials of Nephrectomy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 6 recruiting, 6 unknown, 5 active not recruiting. 6 Not applicable, 6 Phase 2, 4 Phase 3, 2 Early Phase 1, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 3, Recruiting 1, Terminated 1, Unknown 1
Phase 26Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 34Recruiting 2, Active not recruiting 1, Completed 1
Early Phase 12Completed 1, Terminated 1
Phase 12Terminated 1, Withdrawn 1

Follow Nephrectomy: new trials by email Literature Review of Nephrectomy trials Research Report on Nephrectomy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial
Balstilimab, Biospecimen Collection, Botensilimab - Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8
Phase 2RecruitingNational Cancer Institute (NCI)162027-05-172026-10-21
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Localized Clear Cell Renal Cell Carcinoma, Resectable Clear Cell Renal Cell Carcinoma
Phase 2RecruitingCity of Hope Medical Center312026-08-282026-10-23
Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy
nephrectomy - Kidney Cancer
Not applicableRecruitingInstitut Paoli-Calmettes602026-05-132026-10-14
Rhomboid Intercostal and Subserratus Plane Block Versus Quadratus Lumborum Block in Management of Postoperative Pain After Open Nephrectomy
Rhomboid intercostal and Sub-serratus nerve block in nephrectomy, Quadratus lumborum nerve block in nephrectomy - Open Nephrectomy Surgery
Not applicableUnknownAin Shams University502025-07-012025-09-11
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Bone Scan, Carboplatin, Computed Tomography - Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3RecruitingChildren's Oncology Group16562025-04-152026-08-25
Safety and Performance Assessment of a First Four Arms on Demand Open Robotic Solution for Assisted PN, RN and RP
Robot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy (PN) or Radical Prostatectomy (RP). - Nephrectomy, Prostatectomy
Not applicableCompletedRob Surgical Systems S.L.152023-11-012026-07-20
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Axitinib plus Toripalimab, nephrectomy - Renal Cell Carcinoma, Neoadjuvant
Phase 3RecruitingZHOU FANGJIAN2982023-04-192026-03-17
HYbrid RObotic Surgery in Urology
Bitrack System-assisted laparoscopic radical/simple nephrectomy - Nephrectomy
Not applicableCompletedRob Surgical Systems S.L.32023-04-112025-03-21
NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma
Pembrolizumab, Stereotactic Ablative Radiotherapy, Nephrectomy - Renal Cell Carcinoma, Clear Cell, Somatic
Phase 2UnknownPeter MacCallum Cancer Centre, Australia202022-02-082024-05-16
Incidence, Course and Outcome of ABMR in Kidney Transplantation
Kidney Transplantation, Immunosuppression, Nephrectomy (kidney donation) - Antibody-mediated Rejection, Kidney Transplantation
UnknownUniversity Medical Center Groningen2252022-01-012023-05-11
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
Kidney transplant - Human Immunodeficiency Virus, End Stage Renal Disease
RecruitingTulane University302021-11-152025-10-02
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery
Axitinib (VEGF-TKI), Cytoreductive Nephrectomy (CN), Metastasectomy (MET) - Metastatic Clear Cell Renal Cell Carcinoma, Recurrent Clear Cell Renal Cell Carcinoma
Phase 2TerminatedUniversity of California, San Francisco62021-02-092025-11-19
The Incidence of Pulmonary Embolism During Nephrectomy
Nephrectomy - Pulmonary Embolism, Renal Cell Carcinoma
CompletedMahidol University4162020-10-012023-03-16
Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System
adrenalectomy for adrenal adenoma - Renal Cell Carcinoma, Bladder Cancer
Not applicableCompletedThe Affiliated Hospital of Qingdao University12020-08-272022-02-16
Factors Associated To Intensive Care Admission And Mortality In Patients With Emphysematous Pyelonephritis
Nephrectomy - Emphysematous Pyelonephritis
UnknownHospital Universitario Dr. Jose E. Gonzalez652020-04-012020-04-01
Donor Outcomes Following Hand-Assisted and Robotic Living Donor Nephrectomy: a Retrospective Review
kidney transplant - Transplant, Kidney Diseases
UnknownMethodist Health System2402019-11-062024-11-20
Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy
nephrectomy - Renal Cell Carcinoma
CompletedPfizer6182019-07-312021-05-19
Cardiovascular Remodeling in Living Kidney Donors With Reduced Glomerular Filtration Rate
Nephrectomy - Cardiovascular Diseases
Active not recruitingOslo University Hospital1092019-02-012025-08-22
Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer
Biopsy, Daratumumab, Laboratory Biomarker Analysis - Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma
Early Phase 1CompletedM.D. Anderson Cancer Center172018-05-292025-01-30
Enzalutamide Before Surgery in Treating Patients With Kidney Cancer
Enzalutamide, Laboratory Biomarker Analysis, Nephrectomy - Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer
Early Phase 1TerminatedRutgers, The State University of New Jersey32017-12-052021-09-16

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Carcinoma, Renal Cell (17)  ·  Kidney Neoplasms (3)  ·  Cardiovascular Diseases (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Adrenal Gland Neoplasms (1)  ·  Charcot-Marie-Tooth disease, Type 1C (1)  ·  Clear-cell metastatic renal cell carcinoma (1)  ·  Emphysematous Pyelonephritis (1)  ·  Fractures, Bone (1)  ·  Hypertension (1)  ·  Hypertrophy, Left Ventricular (1)  ·  Intracranial Aneurysm (1)  ·  Kidney Diseases (1)  ·  Kidney Failure, Chronic (1)  ·  Polycystic Kidney Diseases (1)

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (3)  ·  National Cancer Institute (NCI) (3)  ·  M.D. Anderson Cancer Center (2)  ·  Rob Surgical Systems S.L. (2)  ·  Ain Shams University (1)  ·  Asan Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Children's Oncology Group (1)  ·  City of Hope Medical Center (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Institut Paoli-Calmettes (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Mahidol University (1)  ·  Methodist Health System (1)

Countries

United States (14)  ·  Canada (3)  ·  Australia (2)  ·  China (2)  ·  France (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Egypt (1)  ·  Israel (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Thailand (1)

Top investigators

Adanma Anji Ayanambakkam Attanathi (1)  ·  Alejandro Mejia, MD (1)  ·  Alexandre Danilovic, M.D., Ph. D. (1)  ·  Alfred Luk, MD (1)  ·  Aphichat Suphathamwit, M.D. (1)  ·  Arnaud Mejean, MD PhD (1)  ·  David Y Oh, MD, PhD (1)  ·  Elizabeth A Mullen (1)  ·  Eric Jonasch, MD (1)  ·  Eric Singer (1)  ·  Fairooz Kabbinavar, M.D. (1)  ·  Fangjian Zhou, Professor (1)  ·  Haitao Niu, PhD (1)

Results publications

PMID 10737279, PMID 11328918, PMID 11923603, PMID 12136861, PMID 17113889, PMID 17631348, PMID 18295861, PMID 18353396, PMID 18803341, PMID 19222048, PMID 2056576, PMID 20840327, PMID 24338498, PMID 25840895, PMID 26293795, PMID 26433570, PMID 27123543, PMID 27194259, PMID 27649314, PMID 29860937, PMID 31072702, PMID 31718316, PMID 32843374, PMID 33526329, PMID 34187771, PMID 34751002, PMID 36536472, PMID 36848607, PMID 38606688, PMID 38942046, PMID 41213151, PMID 41693026, PMID 6366247, PMID 7850302, PMID 8212439

NIH funding

P30CA008748 (1), P30CA016056 (1), P30CA016672 (1), P30CA033572 (1), P30CA072720 (1), U10CA180820 (1), U10CA180886 (1), UM1CA186689 (1)